SynCore Biotechnology Co., Ltd.
6 clinical trials · Sponsor
◉ Watch SynCore Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX (NCT03126435) | SynCore Biotechnology Co., Ltd. | 2018-10-16 |
Track SynCore Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.